News
LUMO Labs’ LUMO Fund has secured €6m from Spain’s state-backed investment arm SETT to support early-stage startups across Spain and Europe. The €100m LUMO Fund is a multi-stage venture capital fund covering pre-seed to Series A investments. It plans to invest in around 30 to 35 startups over the next four years. The fund also [...]
Azenta has acquired UK Biocentre, a UK provider of sample management, storage and high-throughput sample processing services, in a deal worth up to £20.5m. The acquisition was completed through Azenta’s wholly owned subsidiary Azenta UK Ltd. Azenta said the deal strengthens its ability to deliver end-to-end lifecycle solutions in the UK while expanding its presence [...]
AI health platform Qura has raised €1.5m in pre-seed funding to support its plans to improve how non-emergency health conditions are managed across Europe. The funding will be used to expand hiring across medical, engineering and operations teams, invest in digital marketing and community-led growth, advance Qura’s AI health intelligence capabilities and prepare for expansion [...]
MyWay Digital Health has secured £3m in funding to scale its diabetes management platform, which is used across several NHS regions. The Edinburgh-based company, spun out of the University of Dundee in 2017, employs 30 staff across Dundee, Edinburgh and London. It develops data-driven technology to support the management of long-term conditions, with a particular [...]
NHS England has introduced a new depreciation timeline for CIS1, requiring trusts to move completely to CIS2 by 28 February 2027, when access to CIS1 will be removed. Andrew Harrison, director, product management - international at Imprivata, discusses the drive for more secure access to electronic patient record systems that is affecting hospitals in the [...]
Ease Health has launched with US$41m in early-stage funding to expand adoption of its behavioural health software platform among large providers treating mental health and substance use conditions. The New York-based startup has developed a platform that combines admissions processing, patient management and billing tools for behavioural health providers. Many providers rely on two separate [...]
Generate:Biomedicines has raised US$400m in the year’s biggest biotech IPO so far, with proceeds earmarked for clinical trials and R&D on its artificial intelligence platform. The drug developer, which focuses on immunology and inflammation as well as oncology, priced shares at US$16 and began trading on the Nasdaq Global Market under the symbol GENB. [...]
Esperion Therapeutics has agreed to acquire Corstasis Therapeutics in a deal worth up to US$255m, adding a nasal spray treatment for heart failure-related fluid retention to its portfolio. Under the agreement, Esperion will pay US$75m in upfront cash for all outstanding Corstasis shares. Shareholders may also receive up to US$180m in additional payments linked to [...]
The NHS is the most trusted organisation for responsible AI use in the UK, according to a survey of citizens and public sector workers. The findings come from the 2026 UK Public Sector AI Adoption Outlook, conducted by Censuswide on behalf of software firm Appian, which surveyed 1,000 UK public sector workers and 1,000 UK [...]
Alcidion today announces that Miya Precision Concept Detection has been included on the Australian Register of Therapeutic Goods (ARTG – #522634) as a Class 1 Medical Device. The capability has also been successfully registered as a Class 1 Medical Device with the Medicines and Healthcare products Regulatory Agency (MHRA) in the United Kingdom. Concept Detection [...]
